SAFETY AND EFFICACY OF RITUXIMAB IN ADULT WITH CHRONIC IMMUNE THROMBOCYTOPENIA

被引：0
|
作者：
Biagiotti, C. [1 ]
Carrai, V. [1 ]
Bacchiarri, F. [1 ]
Alterini, R. [1 ]
Rigacci, L. [1 ]
Antonioli, E. [1 ]
Di Gioia, M. [1 ]
Raugei, G. [1 ]
Bosi, A. [1 ]
机构：
[1] Careggi Hosp, Hematol, Florence, Italy
来源：
HAEMATOLOGICA | 2015年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P176
引用
收藏
页码：124 / 124
页数：1
相关论文
共 50 条
  • [31] Safety and efficacy of azathioprine in immune thrombocytopenia
    Mishra, Kundan
    Pramanik, Suman
    Sandal, Rajeev
    Jandial, Aditya
    Sahu, Kamal Kant
    Singh, Kanwaljeet
    Khera, Sanjeev
    Meshram, Ashok
    Khurana, Harshit
    Somasundaram, Venkatesan
    Kumar, Rajiv
    Kapoor, Rajan
    Verma, Tarun
    Sharma, Sanjeevan
    Singh, Jasjit
    Das, Satyaranjan
    Chaterjee, Tathagat
    Sharma, Ajay
    Nair, Velu
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2021, 11 (03): : 217 - 226
  • [32] Efficacy and safety of low-dose rituximab combined with different dosage of glucocorticoids for immune thrombocytopenia
    邢伟伟
    ChinaMedicalAbstracts(InternalMedicine), 2013, 30 (03) : 185 - 186
  • [33] Long-Term Safety and Efficacy of Sutimlimab in Patients with Chronic Immune Thrombocytopenia
    Broome, Catherine M.
    Roth, Alexander
    Kuter, David J.
    Scully, Marie
    Smith, Roy
    Wang, Jennifer
    Jiang, Xiaoyu
    Reuter, Caroline
    Daak, Ahmed
    Hobbs, William
    BLOOD, 2020, 136
  • [34] Safety and efficacy of classical complement pathway inhibition with sutimlimab in chronic immune thrombocytopenia
    Broome, Catherine M.
    Roeth, Alexander
    Kuter, David J.
    Scully, Marie
    Smith, Roy
    Wang, Jennifer
    Reuter, Caroline
    Hobbs, William
    Daak, Ahmed
    BLOOD ADVANCES, 2023, 7 (06) : 987 - 996
  • [35] Efficacy of rituximab in primary immune thrombocytopenia: an analysis of adult pretreated patients from everyday hematological practice
    Cervinek, Libor
    Cerna, Olga
    Caniga, Miroslav
    Konirova, Eva
    Hlusi, Antonin
    Simkovic, Martin
    Pospisil, Zdenek
    Cermak, Jaroslav
    Kozak, Tomas
    Mayer, Jiri
    Doubek, Michael
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 96 (05) : 594 - 599
  • [36] Efficacy of rituximab in primary immune thrombocytopenia: an analysis of adult pretreated patients from everyday hematological practice
    Libor Červinek
    Olga Černá
    Miroslav Čaniga
    Eva Konířová
    Antonín Hluší
    Martin Šimkovič
    Zdeněk Pospíšil
    Jaroslav Čermák
    Tomáš Kozák
    Jiří Mayer
    Michael Doubek
    International Journal of Hematology, 2012, 96 : 594 - 599
  • [37] Efficacy and safety of rituximab given at 1,000 mg on days 1 and 15 compared to the standard regimen to treat adult immune thrombocytopenia
    Mahevas, Matthieu
    Ebbo, Mikael
    Audia, Sylvain
    Bonnotte, Bernard
    Schleinitz, Nicolas
    Durand, Jean-Marc
    Chiche, Laurent
    Khellaf, Medhi
    Bierling, Philippe
    Roudot-Thoraval, Francoise
    Godeau, Bertrand
    Michel, Marc
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (10) : 858 - 861
  • [38] Efficacy and safety of two rituximab biosimilars for treating immune thrombocytopenia: a reference-product matched study
    Mageau, Arthur
    Bonnotte, Bernard
    Ebbo, Mikael
    Dossier, Antoine
    Galicier, Lionel
    Souchaud-Debouverie, Odile
    Orvain, Corentin
    Gerfaud-Valentin, Mathieu
    Gobert, Delphine
    Riviere, Etienne
    Audia, Sylvain
    Mahevas, Matthieu
    Michel, Marc
    Viallard, Jean-Francois
    Godeau, Bertrand
    PLATELETS, 2023, 34 (01)
  • [39] The Efficacy and Safety of Different Dosages of Rituximab for Adults with Immune Thrombocytopenia: A Systematic Review and Meta-Analysis
    Dong, Yu
    Yue, Ming
    Hu, Mengjiao
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [40] The efficacy and safety of low-dose rituximab in immune thrombocytopenia: a systematic review and meta-analysis
    Li, Yunjie
    Shi, Yuye
    He, Zhengmei
    Chen, Qiuni
    Liu, Zhenyou
    Yu, Liang
    Wang, Chunling
    PLATELETS, 2019, 30 (06) : 690 - 697
12345